Human iPS cell-derived dopaminergic neurons function in a primate Parkinson’s disease model

No abstract is available for this paper.

• Publication year

  2017

• Venue

  Nature

• Publication date

  2017-08-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1038/nature23664PMID 28858313
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Predictive Markers Guide Differentiation to Improve Graft Outcome in Clinical Translation of hESC-Based Therapy for Parkinson’s Disease

  2017cited by this paper
• Idiopathic Parkinson's disease patient‐derived induced pluripotent stem cells function as midbrain dopaminergic neurons in rodent brains

  2017cited by this paper
• Fail-Safe Therapy by Gamma-Ray Irradiation Against Tumor Formation by Human-Induced Pluripotent Stem Cell-Derived Neural Progenitors

  2016cited by this paper
• Extensive graft-derived dopaminergic innervation is maintained 24 years after transplantation in the degenerating parkinsonian brain

  2016cited by this paper
• Characterization of Fetal Antigen 1/Delta-Like 1 Homologue Expressing Cells in the Rat Nigrostriatal System: Effects of a Unilateral 6-Hydroxydopamine Lesion

  2015cited by this paper
• Successful function of autologous iPSC-derived dopamine neurons following transplantation in a non-human primate model of Parkinson's disease.

  2015cited by this paper
• A novel efficient feeder-free culture system for the derivation of human induced pluripotent stem cells

  2014cited by this paper
• Isolation of Human Induced Pluripotent Stem Cell-Derived Dopaminergic Progenitors by Cell Sorting for Successful Transplantation

  2014cited by this paper
• An Efficient Nonviral Method to Generate Integration‐Free Human‐Induced Pluripotent Stem Cells from Cord Blood and Peripheral Blood Cells

  2013cited by this paper
• Disease-specific phenotypes in dopamine neurons from human iPS-based models of genetic and sporadic Parkinson's disease

  2012cited by this paper
• Laminin E8 fragments support efficient adhesion and expansion of dissociated human pluripotent stem cells

  2012cited by this paper
• Generation of regionally specified neural progenitors and functional neurons from human embryonic stem cells under defined conditions.

  2012cited by this paper
• Prolonged Maturation Culture Favors a Reduction in the Tumorigenicity and the Dopaminergic Function of Human ESC‐Derived Neural Cells in a Primate Model of Parkinson's Disease

  2012cited by this paper
• In Vivo Expression of Cyclooxygenase-1 in Activated Microglia and Macrophages During Neuroinflammation Visualized by PET with 11C-Ketoprofen Methyl Ester

  2011cited by this paper
• Survival of Human Induced Pluripotent Stem Cell–Derived Midbrain Dopaminergic Neurons in the Brain of a Primate Model of Parkinson's Disease

  2011cited by this paper
• An MRI based average macaque monkey stereotaxic atlas and space (MNI monkey space)

  2011cited by this paper
• Small‐molecule inhibitors of bone morphogenic protein and activin/nodal signals promote highly efficient neural induction from human pluripotent stem cells

  2011cited by this paper
• Signs of Degeneration in 12–22-Year Old Grafts of Mesencephalic Dopamine Neurons in Patients with Parkinson's Disease

  2011cited by this paper
• Floor plate-derived dopamine neurons from hESCs efficiently engraft in animal models of PD

  2011cited by this paper
• LRRK2 mutant iPSC-derived DA neurons demonstrate increased susceptibility to oxidative stress.

  2011cited by this paper
• Differentiated Parkinson patient-derived induced pluripotent stem cells grow in the adult rodent brain and reduce motor asymmetry in Parkinsonian rats

  2010cited by this paper
• Striatal volume differences between non-human and human primates.

  2009cited by this paper
• Wnt antagonism of Shh facilitates midbrain floor plate neurogenesis

  2009cited by this paper
• Highly efficient neural conversion of human ES and iPS cells by dual inhibition of SMAD signaling

  2009cited by this paper
• In vivo biosafety model to assess the risk of adverse events from retroviral and lentiviral vectors.

  2008cited by this paper
• Influence of cell preparation and target location on the behavioral recovery after striatal transplantation of fetal dopaminergic neurons in a primate model of Parkinson's disease.

  2008cited by this paper
• Reference and target region modeling of [11C]-(R)-PK11195 brain studies.

  2007cited by this paper
• Midbrain expression of Delta-like 1 homologue is regulated by GDNF and is associated with dopaminergic differentiation.

  2007cited by this paper
• Differences in neurogenic potential in floor plate cells along an anteroposterior location: midbrain dopaminergic neurons originate from mesencephalic floor plate cells

  2007cited by this paper
• Assessment of 11C-PE2I Binding to the Neuronal Dopamine Transporter in Humans with the High-Spatial-Resolution PET Scanner HRRT

  2007cited by this paper
• Reduced midbrain dopamine transporter binding in male adolescents with attention-deficit/hyperactivity disorder: association between striatal dopamine markers and motor hyperactivity.

  2005cited by this paper
• Dopaminergic neurons generated from monkey embryonic stem cells function in a Parkinson primate model.

  2005cited by this paper
• Derivation of midbrain dopamine neurons from human embryonic stem cells.

  2004cited by this paper
• Advances in functional and structural MR image analysis and implementation as FSL.

  2004cited by this paper
• Effect of Dopamine Loss and the Metabolite 3-O-Methyl-[18F]Fluoro-dopa on the Relation between the 18F-Fluorodopa Tissue Input Uptake Rate Constant Kocc and the [18F]Fluorodopa Plasma Input Uptake Rate Constant Ki

  2003cited by this paper
• A double‐blind controlled trial of bilateral fetal nigral transplantation in Parkinson's disease

  2003cited by this paper
• Improved Optimization for the Robust and Accurate Linear Registration and Motion Correction of Brain Images

  2002cited by this paper
• Fast robust automated brain extraction

  2002cited by this paper
• Segmentation of brain MR images through a hidden Markov random field model and the expectation-maximization algorithm

  2001cited by this paper
• Transplantation of embryonic dopamine neurons for severe Parkinson's disease.

  2001cited by this paper
• Hierarchical linear modeling of FIM instrument growth curve characteristics after spinal cord injury.

  2001cited by this paper
• A global optimisation method for robust affine registration of brain images

  2001cited by this paper
• Comparison of eight clinical rating scales used for the assessment of MPTP-induced parkinsonism in the Macaque monkey.

  2000cited by this paper
• A homeodomain gene Ptx3 has highly restricted brain expression in mesencephalic dopaminergic neurons.

  1997cited by this paper
• Distribution Volume Ratios without Blood Sampling from Graphical Analysis of PET Data

  1996cited by this paper
• Graphical Evaluation of Blood-to-Brain Transfer Constants from Multiple-Time Uptake Data. Generalizations

  1985cited by this paper
• Graphical Evaluation of Blood-to-Brain Transfer Constants from Multiple-Time Uptake Data

  1983cited by this paper

• Two decades of induced pluripotent stem cell research: From discovery to diverse applications.

  2026cites this paper
• Investigating the efficacy, methods, and challenges of induced pluripotent stem cells (iPSC) therapy in Parkinson's disease

  2026cites this paper
• The immunological profile of RC17 hESC-derived dopaminergic neural progenitor cells in vitro: Implications for the STEM-PD clinical trial.

  2026cites this paper
• Cell therapy strategies for organ regeneration.

  2026cites this paper
• Induced pluripotent stem cells in autism research: a review of current advances and future directions

  2026cites this paper
• Alleviation of mutant TDP-43-mediated neuropathology by inducible stem cells in monkeys

  2026cites this paper
• Stem cell-based therapies for silicosis: mechanisms, sources, clinical translation, and emerging strategies.

  2026cites this paper
• Early and non-destructive prediction of the differentiation efficiency of human induced pluripotent stem cells using imaging and machine learning

  2025influential citation
• Designing signaling environments to modulate neural progenitor cell differentiation with regulatory network models

  2025influential citation
• Protein regulatory network mediated by palmitoylation modifications in the pathological progression of Parkinson’s disease: a narrative review

  2025cites this paper
• Characterization of the intraspecies chimeric mouse brain at embryonic day 12.5

  2025cites this paper
• Control of immune response in an iPSC-based allogeneic cell therapy clinical trial for Parkinson's disease.

  2025cites this paper
• Towards the establishment of treatments for neurodegenerative diseases using human iPSCs.

  2025cites this paper
• Supramolecular nanostructure mimics GDNF trophic effects in vitro on human dopaminergic neurons

  2025influential citation
• Two parallel lineage-committed progenitors contribute to the developing brain

  2025cites this paper
• The TransEuro open-label trial of human fetal ventral mesencephalic transplantation in patients with moderate Parkinson’s disease

  2025cites this paper
• Human Induced Pluripotent Stem Cells: Directed Differentiation Methods and Applications in Brain Diseases

  2025cites this paper
• Advantages and challenges of using allogeneic vs. autologous sources for neuronal cell replacement in Parkinson’s disease: Insights from non-human primate studies

  2025influential citation
• Phase I/II trial of iPS-cell-derived dopaminergic cells for Parkinson’s disease

  2025cites this paper
• An immunomodulatory encapsulation system to deliver human iPSC-derived dopaminergic neuron progenitors for Parkinson's disease treatment.

  2025cites this paper
• Somatic cell reprogramming for Parkinson's disease treatment

  2025influential citation
• Pluripotent stem-cell-derived therapies in clinical trial: A 2025 update.

  2025cites this paper
• Current therapeutic strategies in Parkinson’s disease: Future perspectives

  2025cites this paper
• Critical analysis of translational potential of rodent models of white matter pathology across a wide spectrum of human diseases

  2025cites this paper
• Adult hippocampal neurogenesis: New avenues for treatment of brain disorders

  2025cites this paper
• THE USE OF STEM CELLS IN NEUROLOGY

  2025cites this paper
• The role of personalized precision medicine in enhancing diagnostic accuracy and clinical outcomes

  2025cites this paper
• Exploring the Emerging Role of Stem Cell Therapy in Neurodegenerative Diseases and Spinal Cord Injury: A Narrative Review

  2025cites this paper
• Regulation of MCCC1 expression by a Parkinson’s disease-associated intronic variant: implications for pathogenesis

  2025cites this paper
• Neuroprotective Effects of Paeonia lactiflora Through the Regulation of Gut Dubosiella in an MPTP-Induced Parkinson's Disease Mouse Model.

  2025cites this paper
• A Neuroprotective Microenvironment was Constructed for Dopaminergic Neuron Grafts Using Autologous Treg Cells

  2025cites this paper
• Electrophysiological characterisation of intranigral-grafted hiPSC-derived dopaminergic neurons in a mouse model of Parkinson’s disease

  2025cites this paper
• Characterization of the intraspecies chimeric mouse brain at embryonic day 12.5

  2025cites this paper
• Sulfide regulation and catabolism in health and disease

  2025cites this paper
• Non‐human primate models of Parkinson's disease: Decoding pathogenesis and advancing therapies

  2025cites this paper
• Allogenic transplantation therapy of iPS cell-derived dopamine progenitors for Parkinson's disease -Current status of the Kyoto Trial and future perspectives.

  2025cites this paper
• iPSC-based cell replacement therapy: from basic research to clinical application.

  2025cites this paper
• Autologous cells, no longer lost in translation.

  2025cites this paper
• Traumatic brain injury and neurodegenerative diseases: the role of axonal injury and amyloid-β.

  2025cites this paper
• Imaging of human stem cell-derived dopamine grafts correlates with behavioural recovery and reveals microstructural brain changes.

  2025cites this paper
• Bexarotene Promotes Neuroblastoma SH-SY5Y Cell Differentiation to Mature Neurons with Decreased Proliferation

  2025cites this paper
• Cell-based regenerative and rejuvenation strategies for treating neurodegenerative diseases

  2025cites this paper
• Human stem cell–based cell replacement therapy for Parkinson’s disease: Enhancing the survival of postmitotic dopamine neuron grafts

  2025cites this paper
• Clinical perspective on pluripotent stem cells derived cell therapies for the treatment of neurodegenerative diseases.

  2025cites this paper
• Two- and Three-Dimensional In Vitro Models of Parkinson’s and Alzheimer’s Diseases: State-of-the-Art and Applications

  2025cites this paper
• Cell reprogramming: methods, mechanisms and applications

  2025cites this paper
• A cloaked human stem-cell-derived neural graft capable of functional integration and immune evasion in rodent models.

  2025cites this paper
• Human Pluripotent Stem Cell-Based Therapies for Parkinson’s Disease: Challenges and Potential Solutions

  2025cites this paper
• Differentiation and regulation of CD4+ T cell subsets in Parkinson’s disease

  2024cites this paper
• Formation and Long-Term Culture of hiPSC-Derived Sensory Nerve Organoids Using Microfluidic Devices

  2024cites this paper
• Epigenetic and transcriptional regulation of neuron phenotype.

  2024cites this paper
• Brain repair mechanisms after cell therapy for stroke

  2024cites this paper
• Modulation of human induced neural stem cell-derived dopaminergic neurons by DREADD reveals therapeutic effects on a mouse model of Parkinson’s disease

  2024cites this paper
• iPS cell therapy 2.0: Preparing for next‐generation regenerative medicine

  2024cites this paper
• Cell-Based Therapy for Fibrosing Interstitial Lung Diseases, Current Status, and Potential Applications of iPSC-Derived Cells

  2024cites this paper
• Past, present, and future of cell replacement therapy for parkinson’s disease: a novel emphasis on host immune responses

  2024cites this paper
• Regenerative rehabilitation: a novel multidisciplinary field to maximize patient outcomes

  2024cites this paper
• In and out: Benchmarking in vitro, in vivo, ex vivo, and xenografting approaches for an integrative brain disease modeling pipeline

  2024cites this paper
• Purification technologies for induced pluripotent stem cell therapies

  2024cites this paper
• The history and status of dopamine cell therapies for Parkinson's disease

  2024cites this paper
• The loaded matrix: neurotrophin-enriched hydrogels for stem cell brain repair in Parkinson’s disease

  2024cites this paper
• Possible Roles of Epigenetics in Stem Cell Therapy for Parkinson’s Disease

  2024cites this paper
• Long-term engraftment and maturation of autologous iPSC-derived cardiomyocytes in two rhesus macaques.

  2024cites this paper
• Human-mouse chimeric brain models constructed from iPSC-derived brain cells: Applications and challenges.

  2024cites this paper
• Human amniotic epithelial stem cell-derived dopaminergic neuron-like cells ameliorate motor dysfunction in a rat model of Parkinson's disease.

  2024cites this paper
• Rotenone-induced PINK1/Parkin-mediated mitophagy: establishing a silkworm model for Parkinson’s disease potential

  2024cites this paper
• Direct conversion of human umbilical cord mesenchymal stem cells into dopaminergic neurons for Parkinson's disease treatment.

  2024cites this paper
• Research progress of cell treatment strategy in Parkinson's disease

  2024cites this paper
• Engineering of rhesus monkey pluripotent stem cells for noninvasive survey and remote control after brain allotransplantation

  2024cites this paper
• Clinical translation of pluripotent stem cell-based therapies: successes and challenges

  2024cites this paper
• Dopaminergic Cell Replacement for Parkinson’s Disease: Addressing the Intracranial Delivery Hurdle

  2024cites this paper
• Evaluation of the Efficacy of Stem Cells Therapy in the Periodontal Regeneration: A Meta-Analysis and Mendelian Randomization Study

  2024cites this paper
• Survival and maturation of human induced pluripotent stem cell-derived dopaminergic progenitors in the parkinsonian rat brain is enhanced by transplantation in a neurotrophin-enriched hydrogel

  2024influential citation
• Human stem cell transplantation for Parkinson’s disease: A systematic review of in situ survival and maturation of progenitors derived from human embryonic or induced stem cells in Parkinsonian models

  2024cites this paper
• Can pluripotent/multipotent stem cells reverse Parkinson’s disease progression?

  2024cites this paper
• Developing Humanized Animal Models with Transplantable Human iPSC-Derived Cells.

  2024cites this paper
• Graft-derived neurons and bystander effects are maintained for six months after human iPSC-derived NESC transplantation in mice’s cerebella

  2024cites this paper
• Continuous immunosuppression is required for suppressing immune responses to xenografts in non-human primate brains

  2024cites this paper
• Apoptosis signal-regulating kinase 1 (Ask1) deficiency alleviates MPP+-induced impairment of evoked dopamine release in the mouse hippocampus

  2024cites this paper
• Proteomic Approach Using DIA-MS Identifies Morphogenesis-Associated Proteins during Cardiac Differentiation of Human iPS Cells

  2024cites this paper
• Induced pluripotent stem cell–related approaches to generate dopaminergic neurons for Parkinson’s disease

  2024cites this paper
• Exercise your graft - An important lesson for cell replacement therapy for Parkinson's disease.

  2024cites this paper
• Host-to-graft propagation of inoculated α-synuclein into transplanted human induced pluripotent stem cell-derived midbrain dopaminergic neurons

  2024cites this paper
• Microinstrumentation for Brain Organoids

  2024cites this paper
• Harnessing the Stem Cell Niche in Regenerative Medicine: Innovative Avenue to Combat Neurodegenerative Diseases

  2024cites this paper
• Combining physical & cognitive training with iPSC-derived dopaminergic neuron transplantation promotes graft integration & better functional outcome in parkinsonian marmosets.

  2024cites this paper
• Dimethyltryptamine (DMT) and ibogaine elicit membrane effects in HEK cells transiently transfected with the human 5-HT2A receptor.

  2024cites this paper
• Induced Pluripotent Stem Cells in Drug Discovery and Neurodegenerative Disease Modelling

  2024cites this paper
• Application Prospect of Induced Pluripotent Stem Cells in Organoids and Cell Therapy

  2024cites this paper
• Stem Cell-Based Approaches in Parkinson’s Disease Research

  2024cites this paper
• A systematic review of progenitor survival and maturation in Parkinsonian models

  2024cites this paper
• [Rho kinase inhibitor Y27632 promotes survival of human induced pluripotent stem cells during differentiation into functional midbrain dopaminergic progenitor cells in vitro].

  2024cites this paper
• Conclusive demonstration of iatrogenic Alzheimer’s disease transmission in a model of stem cell transplantation

  2024cites this paper
• Study on the Extrapolability of Current Tumorgenicity Test With Mice by Comparing the Syngeneic or Allogeneic Mouse Transplantation Model

  2024cites this paper
• Neural Stem Cell Therapy for Alzheimer’s Disease: A-State-of-the-Art Review

  2024cites this paper
• Circuit integration by transplanted human neurons.

  2024cites this paper
• Dopaminergic Axon Tracts Within a Hyaluronic Acid Hydrogel Encasement to Restore the Nigrostriatal Pathway

  2024cites this paper
• Targeting modulation of intestinal flora through oral route by an antimicrobial nucleic acid-loaded exosome-like nanovesicles to improve Parkinson's disease.

  2024cites this paper
• Molecular Mechanisms of Degeneration in Parkinson’s Disease; Deep Brain Stimulation, Pluripotent Stem Cell Therapy, and Cutting Edge Technology in Treatment Of Parkinson’s Disease

  2024cites this paper
• Reprogramming of Expanded Cord Blood-Derived CD34 + Cells from Umbilical Cord-Mesenchymal Stromal Cell Co-Culture to Generate Human-Induced Pluripotent Stem Cells

  2024influential citation